ArticleAnnals of surgical oncology2026

Development and Validation of a Pathomics-Based Prognostic Model for Patients with Lung Adenocarcinoma Undergoing First-Line EGFR-TKI Therapy.

Chunli Kong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.